Novo Nordisk Revenue 2024 In Us Dollars. Novo nordisk ebitda for the twelve months ending september 30,. Novo nordisk said it expects results from a second phase 3 trial of the medicine, this one in people with type 2 diabetes, in the first half of 2025.
Ozempic maker novo nordisk’s plunge echoes nokia risk denmark’s national champion looks like another european first mover being overtaken by a us rival. Novo nordisk’s stock tripled in that period, to more than.